A longitudinal prospective study of active tuberculosis in a Western Europe setting: insights and findings.
Arantxa Romero-Tamarit, Xavier Vallès, María Munar-García...
https://pubmed.ncbi.nlm.nih.gov/38349459Actively Recruiting
All Genders
ID03691883
Design of an Integrative Algorithm for Staging Tuberculosis to Improve Clinical Management
Led by Fundació Institut Germans Trias i Pujol · Updated on 2024-12-27
200
Participants Needed
5
Research Sites
454 weeks
Total Duration
On this page
Sponsors
F
Fundació Institut Germans Trias i Pujol
Lead Sponsor
H
Hospital Universitari Vall d'Hebron (Drassanes)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Tuberculosis is a chronic infectious disease affecting millions worldwide, including about 300 new cases annually in Barcelona. It poses significant public health challenges and is linked to other diseases as well as various social and psychological factors. This research aims to develop a new integrative method to stage tuberculosis disease more effectively, improving understanding and management. The study does not involve specific drug interventions but focuses on designing an integrative algorithm to stage tuberculosis. This innovative approach combines clinical, microbiological, and possibly other relevant data to better characterize the disease stages for improved clinical management. Participants diagnosed with tuberculosis confirmed by microbiological tests will be involved, with clinical management occurring at designated hospitals. Researchers will assess clinical and microbiological changes at the start, after 2 months, 6 months, and for certain cases, at 12 months. The study monitors how tuberculosis progresses and responds over time, aiming to enhance treatment strategies through better disease staging.
CONDITIONS
Official Title
Design of an Integrative Algorithm for Staging Tuberculosis
Who Can Participate
All Genders
Eligibility Criteria
You may qualify if you...
- Tuberculosis diagnosis (all forms) confirmed by microbiological tests (AFB+, GenXpert+, or Culture+)
- Clinical management at Hospital Universitari Vall d'Hebron-Drassanes or Hospital Universitari Germans Trias i Pujol
You will not qualify if you...
- Not consenting to donate data or samples
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Trial Site Locations
Total: 5 locations
1
Hospital Universitari Germans Trias i Pujol
Badalona, Barcelona, Spain, 08916
Actively Recruiting
2
Hospital Sant Joan de Déu
Esplugues de Llobregat, Barcelona, Spain, 08950
Actively Recruiting
3
Hospital del Mar
Barcelona, Spain, 08003
Actively Recruiting
4
Hospital Universitari Vall d'Hebron-Drassanes
Barcelona, Spain
Actively Recruiting
5
Servicios Clínicos de Barcelona
Barcelona, Spain
Actively Recruiting
Loading map...
Research Team
C
Cris Vilaplana, MD, PhD
L
Laura Villegas
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Published Research Related To This Trial
Disseminated tuberculosis and diagnosis delay during the COVID-19 era in a Western European country: a case series analysis.
Sílvia Roure, Xavier Vallès, Nieves Sopena...
https://pubmed.ncbi.nlm.nih.gov/37275492Specific Interventions for Implementing a Patient-Centered Approach to TB Care in Low-Incidence Cities.
Adrià Pujol-Cruells, Cristina Vilaplana
https://pubmed.ncbi.nlm.nih.gov/31850353